Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

372 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Noninvasive In Vivo Coronary Artery Thrombus Imaging.
Tzolos E, Bing R, Andrews J, MacAskill MG, Tavares AAS, Macnaught G, Clark T, Mills NL, Fujisawa T, Nash J, Dey D, Slomka PJ, Koglin N, Stephens AW, Deutsch MA, van Beek EJR, Williams MC, Hermann S, Hugenberg V, Dweck MR, Newby DE. Tzolos E, et al. Among authors: hermann s. JACC Cardiovasc Imaging. 2023 Jun;16(6):820-832. doi: 10.1016/j.jcmg.2022.10.002. Epub 2022 Dec 14. JACC Cardiovasc Imaging. 2023. PMID: 36526577 Free article.
A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.
Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S. Hugenberg V, et al. Among authors: hermann s. J Med Chem. 2012 May 24;55(10):4714-27. doi: 10.1021/jm300199g. Epub 2012 May 16. J Med Chem. 2012. PMID: 22540974
Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.
Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S. Hugenberg V, et al. Among authors: hermann s. J Med Chem. 2013 Sep 12;56(17):6858-70. doi: 10.1021/jm4006753. Epub 2013 Aug 16. J Med Chem. 2013. PMID: 23899323
Synthesis and evaluation of a [18F]BODIPY-labeled caspase-inhibitor.
Ortmeyer CP, Haufe G, Schwegmann K, Hermann S, Schäfers M, Börgel F, Wünsch B, Wagner S, Hugenberg V. Ortmeyer CP, et al. Among authors: hermann s. Bioorg Med Chem. 2017 Apr 1;25(7):2167-2176. doi: 10.1016/j.bmc.2017.02.033. Epub 2017 Feb 16. Bioorg Med Chem. 2017. PMID: 28284866
Synthesis, radiosynthesis, in vitro and first in vivo evaluation of a new matrix metalloproteinase inhibitor based on γ-fluorinated α-sulfonylaminohydroxamic acid.
Hugenberg V, Behrends M, Wagner S, Hermann S, Schäfers M, Kolb HC, Szardenings K, Walsh JC, Gomez LF, Kopka K, Haufe G. Hugenberg V, et al. Among authors: hermann s. EJNMMI Radiopharm Chem. 2018 Jul 27;3:10. doi: 10.1186/s41181-018-0045-0. eCollection 2018 Dec. EJNMMI Radiopharm Chem. 2018. PMID: 30101186 Free PMC article.
Radiolabeled hydroxamate-based matrix metalloproteinase inhibitors: How chemical modifications affect pharmacokinetics and metabolic stability.
Hugenberg V, Hermann S, Galla F, Schäfers M, Wünsch B, Kolb HC, Szardenings K, Lebedev A, Walsh JC, Mocharla VP, Gangadharmath UB, Kopka K, Wagner S. Hugenberg V, et al. Among authors: hermann s. Nucl Med Biol. 2016 Jul;43(7):424-37. doi: 10.1016/j.nucmedbio.2016.03.005. Epub 2016 Mar 17. Nucl Med Biol. 2016. PMID: 27179748
A Novel Mouse Model of Staphylococcus aureus Vascular Graft Infection: Noninvasive Imaging of Biofilm Development in Vivo.
Van de Vyver H, Bovenkamp PR, Hoerr V, Schwegmann K, Tuchscherr L, Niemann S, Kursawe L, Grosse C, Moter A, Hansen U, Neugebauer U, Kuhlmann MT, Peters G, Hermann S, Löffler B. Van de Vyver H, et al. Among authors: hermann s. Am J Pathol. 2017 Feb;187(2):268-279. doi: 10.1016/j.ajpath.2016.10.005. Epub 2017 Jan 11. Am J Pathol. 2017. PMID: 28088288 Free article.
Diabetic db/db mice do not develop heart failure upon pressure overload: a longitudinal in vivo PET, MRI, and MRS study on cardiac metabolic, structural, and functional adaptations.
Abdurrachim D, Nabben M, Hoerr V, Kuhlmann MT, Bovenkamp P, Ciapaite J, Geraets IME, Coumans W, Luiken JJFP, Glatz JFC, Schäfers M, Nicolay K, Faber C, Hermann S, Prompers JJ. Abdurrachim D, et al. Among authors: hermann s. Cardiovasc Res. 2017 Aug 1;113(10):1148-1160. doi: 10.1093/cvr/cvx100. Cardiovasc Res. 2017. PMID: 28549111
372 results